The recently EU-funded project ID-EPTRI (European Paediatric Translational Research Infrastructure), aimed to design a new Research Infrastructure (RI) in Europe completely dedicated to Paediatrics will be launched on January 15th-16th 2018, at the Ministry of Education, Universities and Research, Sala della Comunicazione, Viale Trastevere, 76/a, Rome, Italy. The project, which is financed under the H2020-INFRADEV-01-2017
TEDDY – European Network of Excellence for Paediatric Clinical Research announces the General Assembly entitled “A new phase for paediatric clinical research: a play role for TEDDY?”, that will be held on January 14th, 2018 at Hotel Ripa in Via degli Orti di Trastevere, 3 Rome – Italy. The TEDDY Network of Excellence arose from the Task-force
Roma, January 2018 - ID-EPTRI (European Paediatric Translational Research Infrastructure) is a project coordinated by Consorzio per Valutazioni Biologiche e Farmacologiche (CVBF-TEDDY) that granted with 3 million of Euros from funding of the European Commission. The main objective of the project lasting 24 months, is to design the framework for a new European Paediatric Research Infrastructure
ENCePP is the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance coordinated by the European Medicines Agency (EMA) aimed to strengthen the monitoring of the benefit-risk balance of medicinal products in Europe.
On 31th May, 2017 the European Medicines Agency (EMA) published an action plan for small and medium-sized enterprises (SMEs), which aims to foster innovation and support SMEs in the development of novel human and veterinary medicines. This action plan builds on existing measures introduced to support SMEs pursuant to Commission Regulation (EC) No 2049/2005 and addresses the
On 25th, July 2017, the European Medicines Agency (EMA) published a revision of the guidance on first-in-human clinical trials, that will come into effect on February 1st, 2018. The guidance addresses non-clinical issues for consideration prior to the first administration of an investigational medicinal product in humans. It also focuses on the design and conduct
In July 2017, the Article “Tuberculosis treatment for children: An update” has been published on-line in “Anales de Pediatría” Journal. The publication reports the updated international guidelines for the management of paediatric Tuberculosis (TB) in Spain, reviewed by a group of paediatric TB experts, among which some researchers of the TEDDY Network, such as Maria
Consorzio per Valutazioni Biologiche e Farmacologiche – Dege e shoqerise se huaj, Albanian Branch Office in collaboration with the TEDDY Network (European Network of Excellence for Paediatric Clinical Research) and University Hospital Center Tirana “Mother Teresa”, Service of Paediatrics), promoted the first YPAG (Young People Advisory Group) in Albania, named KIDS Albania. KIDS Albania
The article “Investigating the roles and training of paediatric research nurses working across Europe: a questionnaire-based survey”, aimed to identify potential training needs and compare the roles of research nurses across specialties and countries, has been published in BMJ Paediatrics Open 2017. Research nurses represent key figures among the clinical trial personnel to conduct a
Also this year the Gianni Benzi Pharmacological Research Foundation organises the annual Foresight Training Course (FTC), at its tenth edition now. The meeting, entitled ‘THE EUROPEAN MEDICINES REGULATORY NETWORK: PRESENT AND FUTURE’, will focus on: – the main innovations in the European Pharmaceutical System; – putting patients in the core of the system; – the